The New York State Department of Health recently proposed new cannabinoid hemp regulation which establishes requirements for licensure for extraction and manufacturing, as well as the sale of hemp-derived cannabidiol (CBD) products. The New York State Department of Health (NYSDH) recently proposed new cannabinoid hemp regulationwhich establishes requirements for licensure for extraction and manufacturing, as well […]

It is clear that cannabidiol (“CBD”) is everywhere and in (almost) everything; in foods, beverages, and even pet foods. What is less clear is how CBD ranks as an enforcement priority for the U.S. Food and Drug Administration (“FDA”) and what the agency expects of manufacturers. Even though FDA has previously not objected to the use […]

The hemp industry has been waiting with bated breath for the release of the U.S. Food and Drug Administration’s Cannabidiol Enforcement Policy Draft Guidance. FDA sent the draft to the White House Office of Management and Budget last July. Of all FDA documents currently under review at the OMB, the CBD policy has been pending […]